U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9NO
Molecular Weight 87.1204
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOBUTYRAMIDE

SMILES

CC(C)C(N)=O

InChI

InChIKey=WFKAJVHLWXSISD-UHFFFAOYSA-N
InChI=1S/C4H9NO/c1-3(2)4(5)6/h3H,1-2H3,(H2,5,6)

HIDE SMILES / InChI

Molecular Formula C4H9NO
Molecular Weight 87.1204
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Isobutyramide (VX-366) is an orally available branched chain amide that may offer an alternative to current treatments for beta-hemoglobinopathy. Isobutyramide has been shown to increase fetal hemoglobin (HbF) in patients with beta-hemoglobinopathies. Isobutyramide was originated at the Children's Hospital Oakland Research Institute which, in 1993, granted exclusive worldwide rights for the agent to Vertex. However, development of Isobutyramide has been discontinued for sickle cell anaemia and thalassaemia.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: gamma-globin synthesis
Target ID: fetal-globin synthesis
PubMed

PubMed

TitleDatePubMed
Acetazolamide-based fungal chitinase inhibitors.
2010-12-01
LC-MS profiling of N-alkylamides in Spilanthes acmella extract and the transmucosal behaviour of its main bio-active spilanthol.
2010-11-02
Preliminary studies on local anesthetic and antipyretic activities of Spilanthes acmella Murr. in experimental animal models.
2010-10
Establishment of steady-state metabolism of ethanol in perfused rat liver: the quantitative analysis using kinetic mechanism-based rate equations of alcohol dehydrogenase.
2010-09
Natural toxins for use in pest management.
2010-08
A new acylamidase from Rhodococcus erythropolis TA37 can hydrolyze N-substituted amides.
2010-08
Psychophysical evaluation of a sanshool derivative (alkylamide) and the elucidation of mechanisms subserving tingle.
2010-03-03
Preparation of N-acetyl, tert-butyl amide derivatives of the 20 natural amino acids.
2010-03
Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.
2009-12-18
N,N'-Bis(4-bromo-phen-yl)naphthalene-1,4-dicarboxamide N,N-dimethyl-acetamide disolvate.
2009-12-04
Characteristic and spectroscopic properties of the Schiff-base model compounds.
2009-11
Thalassaemia intermedia: an update.
2009-08-29
Inhibition of androstenediol-dependent LNCaP tumour growth by 17alpha-ethynyl-5alpha-androstane-3alpha, 17beta-diol (HE3235).
2009-04-07
Formation and properties of stabilized aluminum nanoparticles.
2009-03
Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
2009-03
Vasorelaxant and antioxidant activities of Spilanthes acmella Murr.
2008-12
N,N'-Bis(4-methyl-phen-yl)naphthalene-1,4-dicarboxamide N,N-dimethyl-acetamide disolvate.
2008-11-20
Utilization of aliphatic nitriles under haloalkaline conditions by Bacillus alkalinitrilicus sp. nov. isolated from soda solonchak soil.
2008-11
Multiple conformational states in crystals and in solution in alphagamma hybrid peptides. Fragility of the C12 helix in short sequences.
2008-09-05
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
2008-09-01
Chemical dissection of the link between streptozotocin, O-GlcNAc, and pancreatic cell death.
2008-08-25
Terminal nickel(ii) amide, alkoxide, and thiolate complexes containing amido diphosphine ligands of the type [N(o-C6H4PR2)2]- (R = Ph, (i)Pr, Cy).
2008-07-07
Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
2008-07
R-stereoselective amidase from Rhodococcus erythropolis No. 7 acting on 4-chloro-3-hydroxybutyramide.
2008-03
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.
2008-02-14
Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways.
2008
Binding to DPF-motif by the POB1 EH domain is responsible for POB1-Eps15 interaction.
2007-12-21
Phytotherapeutic effects of Echinacea purpurea in gamma-irradiated mice.
2007-12
A novel thermostable nitrilase superfamily amidase from Geobacillus pallidus showing acyl transfer activity.
2007-06
Structural evidence for a ligand coordination switch in liver alcohol dehydrogenase.
2007-05-08
Cloning and nucleotide sequence of carbaryl hydrolase gene (cahA) from Arthrobacter sp. RC100.
2006-05
High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts.
2006-01-27
Echinacea: a miracle herb against aging and cancer? Evidence in vivo in mice.
2005-09
In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea).
2005-07
Mass spectral characterization of fatty acid amides from alfalfa trichomes and their deterrence against the potato leafhopper.
2005-03
Evidence for an isobutylamide associated with host-plant resistance to western flower thrips, Frankliniella occidentalis, in chrysanthemum.
2005-01
Investigating the effect of hydrogen bonding environments in amide cleavage reactions at zinc(II) complexes with intramolecular amide oxygen co-ordination.
2004-12-21
Rendering poly(amidoamine) or poly(propylenimine) dendrimers temperature sensitive.
2004-10-13
Purification and properties of an enantioselective and thermoactive amidase from the thermophilic actinomycete Pseudonocardia thermophila.
2004-07
Zinc(II) complexes with intramolecular amide oxygen coordination as models of metalloamidases.
2004-01-07
Isobutylamides of unsaturated fatty acids from Chrysanthemum morifolium associated with host-plant resistance against the western flower thrips.
2003-09
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
2003-03-01
In vitro neuropharmacological evaluation of piperovatine, an isobutylamide from Piper piscatorum (Piperaceae).
2002-12
Separation of alkamides from Echinacea purpurea extracts by cyclodextrin-modified micellar electrokinetic chromatography.
2002-09
Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors.
2002-08
Larvicidal activity of isobutylamides identified in Piper nigrum fruits against three mosquito species.
2002-03-27
Isobutyramide activates transcription of human fetal gamma- and murine embryonic epsilon(y)-globin genes.
2001-12
Redox-induced terpyridyl substitution in the Os(VI)-hydrazido complex, trans-[Os(VI)(tpy)(Cl)(2)(NN(CH(2))(4)O)](2+).
2001-07-30
Effects of semen filtration and dilution rate on morphology and fertility of frozen gander spermatozoa.
2001-06-01
Medicinal and ethnoveterinary remedies of hunters in Trinidad.
2001
Patents

Sample Use Guides

Isobutyramide was administered as a suspension over a period of 3 months, from a starting dose of 50 mg/kg/day up to 150 mg/kg/day, to four adult sickle cell (SS) anemia patients. The maximum dose was maintained for 3 weeks.
Route of Administration: Oral
In Vitro Use Guide
Isobutyramide is essentially an uncompetitive inhibitor of purified rat liver alcohol dehydrogenase (Kii = 0.33 mM)
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:12:31 GMT 2025
Edited
by admin
on Mon Mar 31 18:12:31 GMT 2025
Record UNII
82UOE7B38Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-8423
Preferred Name English
ISOBUTYRAMIDE
Systematic Name English
2-METHYLPROPIONAMIDE
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 82494
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
FDA ORPHAN DRUG 71792
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
Code System Code Type Description
CAS
563-83-7
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID1060340
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
MESH
C030197
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
PUBCHEM
68424
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-265-9
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
WIKIPEDIA
ISOBUTYRAMIDE
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
NSC
8423
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY
RXCUI
1653517
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY RxNorm
FDA UNII
82UOE7B38Z
Created by admin on Mon Mar 31 18:12:31 GMT 2025 , Edited by admin on Mon Mar 31 18:12:31 GMT 2025
PRIMARY